Anticoagulation Forum
- Company typePrivate
- Founded1991
- HeadquartersNewton, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
Anticoagulation Forum firmographics
Firmographics- Name
- Anticoagulation Forum
- Legal name
- Anticoagulation Forum
- Website
- https://acforum.org
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Anticoagulation Forum industry classification
Industry- Product category
- Medical Professional Education Services
- NAICS
- Business Associations (813910), Educational Support Services (611710)
- SIC
- Services-Educational Services (8200), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Association & Society Conference Management (Nonprofit, Professional Bodies) (THAHACAA)
- akta.pro secondary industry
- Preventive Cardiology & Lipidology (HLAKABAF)
Keywords
Where Anticoagulation Forum is headquartered
LocationHeadquarters
- HQ city
- Newton
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Anticoagulation Forum business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Industry Sponsorships and Corporate Partnerships: The organization receives financial support from pharmaceutical and medical device companies including Abbott, Bayer, Boston Scientific, Johnson & Johnson, BMS-Pfizer, Novartis, and others through corporate council membership, exhibition sponsorships, resource sponsorships, and advertising in eNewsletter.
- Conference Bundles and Educational Content Sales: Sale of on-demand conference bundles ($25 per individual bundle or $99 for complete set of 5), Hubs & Spokes premium educational content, and boot camp on-demand programs. CE credits available for additional fee.
- ACE Assessment Fees: Assessment fees for Center of Excellence recognition program: $399 initial assessment, $99 for retake if not passed.
- Donations and Grants: Tax-deductible donations from individuals and organizations supporting the mission. AC Forum is a registered 501(c)(3) nonprofit organization (Taxpayer ID: 03-0474134).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Individual Conference Bundle (50% off promotional) |
| One time/ perpetual license | Pay-as-you-go | Complete Conference Bundle Package (50% off promotional) |
| One time/ perpetual license | Pay-as-you-go | ACE Assessment (Initial) |
| One time/ perpetual license | Pay-as-you-go | ACE Assessment (Retake) |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Anticoagulation Forum product offering
Product offeringCore offering
The Anticoagulation Forum is a nonprofit 501(c)(3) professional association that delivers clinical education, evidence-based guidance, and peer community to healthcare professionals managing antithrombotic therapy. Its core deliverables include the ACE Center of Excellence assessment program, AC University online learning platform, the biennial National Conference, on-demand boot camps, curated clinical guidance, literature updates, and the literature citation library. Free membership provides access to resources, while premium content, assessments, conferences, and continuing education programs are sold separately.
Product overview
The Anticoagulation Forum operates as a web-based educational platform providing comprehensive resources for healthcare professionals in anticoagulation management. The core platform consists of the Education & Resource Center housing clinical tools, rapid references, and curated evidence, supported by AC University as the primary educational platform. Key products include the Literature Library (7,000+ curated citations), Antithrombotic Clinical Guidance documents, Antithrombotic Literature Updates, and Archived Webinars covering diverse topics. The organization offers intensive learning through On-Demand Boot Camp (12.0 CE credits) and biennial National Conferences. The ACE (Antithrombotic Center of Excellence) Program provides assessment and 5-year recognition for services meeting best practice standards, while the CARE-AF/VTE Program delivers specialized multi-channel learning. Additional offerings include PGY2 Residency support, Hubs and Spokes premium content modules, Stewardship Webinars, the Innovation Circle peer network, Monthly Newsletter, and Job Center. The portfolio serves multidisciplinary membership including physicians, pharmacists, nurses, and advanced practice providers.
Differentiator
Problem solved
Functional benefit
Brands
- ACE Program: Antithrombotic Center of Excellence Program - helps healthcare services evaluate, strengthen, and sustain high-quality antithrombotic care through structured self-assessment.
- CARE-AF/VTE Program
- IDEA Initiative
- AC University
- Antithrombotic Literature Updates
Products and services
- Antithrombotic Center of Excellence (ACE) Program
Quantifiable outcome
- Over 1 million patients supported annually through member services
- +2 more outcomes
Companies that use Anticoagulation Forum
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Anticoagulation Forum technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Anticoagulation Forum partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered core and minor.
- International Society on Thrombosis and Haemostasis (ISTH)coreStrategic partnership to advance antithrombotic stewardship. Joint initiatives include the CARE-AF/VTE Program and collaboration on global stewardship efforts. AC Forum abstracts from the 18th National Conference were published in Research and Practice in Thrombosis and Haemostasis (RPTH), the ISTH Open Access Journal.
- OpenEvidencecorePartnership to expand access to AI-enabled guidance in antithrombotic care. AC Forum x OpenEvidence initiative advancing antithrombotic stewardship at the point of care through AI-powered clinical decision support.
- International Society of Cardiovascular Pharmacotherapy (ISCP)coreISCP has endorsed the CARE-AF/VTE Program, recognizing the importance of closing gaps in clinician knowledge for optimal DOAC use. Partnership supports global efforts to improve stroke prevention in atrial fibrillation and treatment of VTE.
- Abbott (Acelis INR/Connected Care)minorCorporate sponsor and exhibitor at AC Forum events. Supports anticoagulation education and resources.
- BayerminorCorporate sponsor supporting AC Forum educational initiatives and programs.
- Boston ScientificminorCorporate sponsor and exhibitor supporting AC Forum conferences and educational programs.
- Johnson & Johnson (Janssen)minorCorporate sponsor supporting AC Forum initiatives and programs through exhibition and sponsorship.
- BMS-Pfizer AllianceminorSponsor of AC Forum IDEA Initiative and educational resources on Social Determinants of Health. Corporate Council member supporting anticoagulation education.
- NovartisminorCorporate sponsor supporting AC Forum educational programs and resources.
- PerosphereminorCorporate sponsor supporting AC Forum initiatives.
- AMDA - The Society for Post-Acute and Long-Term Care MedicineminorPartner organization collaborating on anticoagulation care initiatives across care settings.
- American Society of Health-System Pharmacists (ASHP)coreProfessional society partnership supporting PGY2 Residency in Thrombosis and Hemostasis Management. ASHP is the sole accrediting body for pharmacy residency programs.
- Coalition for National Trauma Research (CNTR)minorPartner organization collaborating on trauma-related thrombosis research and education.
- European and Mediterranean League Against Thrombotic Diseases (EMLTD)minorInternational partner organization supporting thrombosis education and research collaboration.
- International Pharmaceutical Federation (FIP)minorGlobal pharmacy organization partnership for international anticoagulation education.
- Foundation for Women & Girls with Bleeding Disorders (FWG)minorPartner organization addressing bleeding and thrombosis issues specific to women and girls.
- National Blood Clot Alliance (NBCA)minorPatient advocacy partner organization working on thrombosis awareness and education.
- Pharmacy Quality Alliance (PQA)minorQuality measurement organization partnership for anticoagulation quality improvement initiatives.
- Sociedad Mexicana de Trombosis y Hemostasia (SOMETH)minorMexican Society of Thrombosis and Hemostasis partnership for international collaboration.
- Thrombosis & Hemostasis Societies of North America (THSNA)coreCoalition partnership advancing thrombosis and hemostasis research and education across North America.
- World Thrombosis Day (WTD)minorGlobal awareness campaign partnership for thrombosis education and prevention.
- Physician-Patient Alliance for Health & Safety (PPAHS)minorPatient safety organization partnership for anticoagulation safety initiatives.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Anticoagulation Forum competitors and assessment
Company assessmentBroad incumbents
- American Heart Association (AHA): A large, well-resourced nonprofit focused on cardiovascular health and stroke. AHA covers antithrombotic and AF-related guidance through scientific statements, professional education, and conferences, sitting one layer above AC Forum's specialist niche.
- American Society of Hematology (ASH): The largest professional society serving hematologists worldwide. ASH covers thrombosis and hemostasis as part of a much broader hematology mandate and competes for the same clinician attention, conference attendance, and sponsor dollars that AC Forum targets in the antithrombotic niche.
Direct peers
- American College of Cardiology (ACC): A major cardiovascular professional society whose membership includes the cardiology specialists who manage stroke prevention, AF, and VTE. ACC competes with AC Forum for cardiology continuing education and sponsor support in overlapping anticoagulation content areas.
- American Society of Health-System Pharmacists (ASHP): The leading U.S. society for hospital and health-system pharmacists and the accreditor of the PGY2 residency in Thrombosis and Hemostasis Management that AC Forum helped create. ASHP is both a strategic partner and a structural competitor for pharmacist-targeted anticoagulation education.
- Society for Vascular Medicine: A medical specialty society for vascular medicine physicians who manage peripheral, venous, and arterial thrombotic disease. It addresses a closely related clinician audience and competes for limited specialty society attention in antithrombotic care.
- Thrombosis & Hemostasis Societies of North America (THSNA): A coalition of North American thrombosis and hemostasis societies. THSNA is an explicit AC Forum coalition partner and an overlapping platform for advancing the same clinical and research agenda across the region.
- International Society on Thrombosis and Haemostasis (ISTH): The leading global scientific society for thrombosis and haemostasis. ISTH is an explicit AC Forum strategic partner (joint CARE-AF/VTE work, RPTH journal publications) and overlaps directly in audience, subject matter, and conference programming for antithrombotic clinicians and researchers.
Regional players
- Anticoagulation UK: A UK-focused charity (formerly Anticoagulation Europe) dedicated to supporting patients and clinicians on anticoagulation. Comparable in mission and education-led model to AC Forum but operating primarily in the United Kingdom rather than competing directly in the U.S. market.
- Thrombosis Canada: A Canadian clinician-led organization producing anticoagulation and thrombosis guidance, education, and clinical tools. Highly comparable in scope and audience to AC Forum's clinical guidance work, but anchored in Canada rather than competing directly for U.S. members.
Others
- National Blood Clot Alliance (NBCA): A U.S. patient advocacy organization focused on blood clot awareness, education, and policy. NBCA is an explicit AC Forum partner and shares the antithrombotic mission from the patient/community side rather than the clinician side, making it an adjacent ecosystem participant.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Anticoagulation Forum social profiles
Digital presenceAnticoagulation Forum financial estimates
Financial estimateRevenue estimate
Valuation estimate
Anticoagulation Forum leadership team
Management profileNumber of profiles
Profiles9 records
Anticoagulation Forum funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Anticoagulation Forum M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Anticoagulation Forum
What does Anticoagulation Forum do?
The Anticoagulation Forum is a nonprofit 501(c)(3) professional association that delivers clinical education, evidence-based guidance, and peer community to healthcare professionals managing antithrombotic therapy. Its core deliverables include the ACE Center of Excellence assessment program, AC University online learning platform, the biennial National Conference, on-demand boot camps, curated clinical guidance, literature updates, and the literature citation library. Free membership provides access to resources, while premium content, assessments, conferences, and continuing education programs are sold separately.
Is Anticoagulation Forum a public or private company?
Anticoagulation Forum is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Anticoagulation Forum founded?
Anticoagulation Forum was founded in 1991. It employs 1 to 10 people.
Where is Anticoagulation Forum based?
Anticoagulation Forum is headquartered in Newton, United States, in the North America region.
How does Anticoagulation Forum make money?
Four revenue lines are on record. Industry Sponsorships and Corporate Partnerships are the primary driver. The others are conference Bundles and Educational Content Sales, ACE Assessment Fees and donations and Grants.
Who are Anticoagulation Forum's main competitors?
Broad incumbents on record are American Heart Association (AHA) and American Society of Hematology (ASH). Direct peers are American College of Cardiology (ACC), American Society of Health-System Pharmacists (ASHP), Society for Vascular Medicine, Thrombosis & Hemostasis Societies of North America (THSNA) and International Society on Thrombosis and Haemostasis (ISTH). Regional players are Anticoagulation UK and Thrombosis Canada. National Blood Clot Alliance (NBCA) is listed as an others.
Does Anticoagulation Forum have an API?
No public API is recorded for Anticoagulation Forum.
What industry is Anticoagulation Forum in?
Anticoagulation Forum's product category is Medical Professional Education Services. Its primary akta.pro industry code is THAHACAA, Association & Society Conference Management (Nonprofit, Professional Bodies), with a secondary code of HLAKABAF, Preventive Cardiology & Lipidology. Its NAICS code is 813910 and its SIC code is 8200.